Natera, Inc. (45E)
FSX
Real-time Data
06:00 AM
Day's Range
352.2052 wk Range
86.00Overview - 45E - Natera, Inc.
Key Statistics
Valuation
Enterprise Value
44.98B
P/E (Trailing)
‪-237.96‬
P/E (Forward)
‪-19.23‬
PEG Ratio
‪6.52‬
Price / Sales (TTM)
‪19.25‬
Price / Book
‪32.73‬
EV / EBITDA
‪-228.51‬
Profitability
Gross Margin
‪64.45%‬
Profit Margin
‪-7.10%‬
Operating Margin
‪-10.29%‬
Return on Assets
‪-8.07%‬
Return on Equity
‪-12.54%‬
Ownership
Shares Outstanding
143.61M
Float
140.09M
Held by Insiders
‪2.81%‬
Held by Institutions
‪96.73%‬
Price stats
Beta
‪1.53‬
50-Day Avg
‪270.96‬
200-Day Avg
‪208.36‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 45E - Natera, Inc.
Peers - 45E - Natera, Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on FSX.
Profile Summary - 45E - Natera, Inc.
About
Natera, Inc. is a molecular diagnostics company that develops and commercializes cell-free DNA and genetic testing services for clinical use. The company focuses on oncology, women’s health, and organ health, using proprietary molecular assays and bioinformatics to help detect and monitor genetic conditions and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
